Free Educational Webinar: Acute Treatment of Migraine

Register Now!

Acute treatment of migraine:  the cornerstone of effective migraine management

Migraine is the 4th leading cause of disability in the world for women and the 19th cause of disability for men.  Much of the disability is a consequence of ineffective acute treatment.  Those with ineffective acute treatment are much more likely to develop chronic migraine and its associated co-morbidities.  There are several effective acute treatment that are available but as many as 70% of people with migraine are willing to try something new.

The discussion on February 16 will focus on how to optimize your acute treatment.  We will discuss a new treatment strategy called “attack-based care” and how to use an educational program called MigrainePro to define and refine your specific acute treatment approaches to migraine.  We will discuss new and old treatments that are available today and how you can create a personalized migraine care kit to more successfully treat acute attacks of migraine.  Hope to see you there and please bring your comments and questions.

 

About Dr. Roger Cady

Roger K. Cady, M.D. is the co-founder and director of the Headache Care Center and founder of Clinvest, a national clinical research organization.

Dr. Cady has authored and co-authored over 200 peer-reviewed journal articles, books, chapters of books, and abstracts; most recently, Headache and Migraine Biology and Management (Academic Press, 2015) and Managing Migraine: A Healthcare Professional’s Guide to Collaborative Migraine Care and Managing Migraine: A Patient’s Guide to Successful Migraine Care (Baxter Publishing, 2008). He was instrumental in developing the early intervention paradigm for treatment of acute migraine and defining “sinus headache” as a common presentation of migraine. Dr. Cady has presented countless lectures and seminars around the world on headache and other chronic disorders, and continues to be the principal investigator for numerous multi-center studies.


Rush University Medical Center Seeking Participants for Sleep-Chronic Migraine Study

Researchers at Rush University Medical Center in Chicago are currently seeking participants for a study examining the sleep patterns of women who experience chronic migraine.

The study intends to test the value of online sleep improvement program Sleepio. The program incorporates principles of cognitive behavioral therapy, or CBT, treatment. It is designed to support people in making changes to their sleep behaviors, thoughts, bedroom environment, and lifestyle—targeting things in their life that can lead to poor sleep. Sleepio has been shown to be effective for individuals with insomnia in a clinical trial.

“We are interested in understanding how effective this kind of program might be for reducing sleep complaints in individuals with migraines, said Megan Crawford, PhD, the principal investigator for the Sleepio study at Rush University. “We also want to know what kind of impact improving sleep will have on migraines.”

Participants for this study may be eligible for this study if they are a female between the ages of 18 and 41; have difficulties falling asleep or staying asleep; and are willing to complete Sleepio, the online treatment program. Participants must also live in the Chicago area or be willing to travel to Chicago for one face-to-face meeting.

For more information about the study, please call Rush University Medical Center at (312) 942-0549.

Download (PDF, 156KB)


DHC Practicing Physician’s Approach to the Difficult Headache Patient

Professionals at the Diamond Headache Clinic’s 29th annual Practicing Physician’s Approach to the Difficult Headache Patient in Newport Beach, California are welcome to visit the National Headache Foundation exhibit.

See the latest edition of HeadWise, pick up brochures and membership information, and learn more about the upcoming Certificate of Added Qualification in Headache Medicine exam.

We look forward to seeing everyone who will be in attendance.


Get Your Tickets for NHF’s Annual Raffle: You Can Win $25,000

2016 Raffle Flyer

Call 1-888-NHF-5552 to reserve your ticket today!

OFFICIAL RULES: The winning ticket will be drawn and announced at the NHF 30th Annual Fundraising Benefit, The Purple Ball, on Saturday, May 21, 2016. The winner need not be present to win. Winner will win $25,000. You must indicate your full name, address and daytime telephone number. Accepted forms of payments are credit card, check or money order for $100 per ticket made payable to the National Headache Foundation. (Credit cards accepted are AmEx, Discover, MC and VISA).

ELIGIBILITY: You must be 18 years or older to purchase a raffle ticket and a resident of the United States. Only one (1) individual may be identified as the purchaser of a raffle ticket. Federal, state and local laws and regulations apply. Void where prohibited. All purchases are final and non-refundable. By entering the raffle, the ticket purchaser acknowledges that he/she is aware of, and agrees with the Raffle Official Rules.

DRAWING: A maximum of 700 tickets will be sold. All entries must be RECEIVED by 5:00pm CT on Friday, May 20, 2016. In the event there are remaining tickets that have not been sold, they will be available for purchase at the NHF’s Benefit, The Purple Ball, to be held at the Ritz-Carlton Chicago on Saturday, May 21, 2016 until 30 minutes prior to the random drawing that will occur at or about 10:00pm CT.

TAXES: The winner is solely responsible for all state and local costs and charges. The winner is also responsible for any and all federal, state and local income or excise taxes, fees, assessments and like charges associated with the prize. The IRS has taken the position that amounts paid for chances to participate in raffles, lotteries or similar programs are not gifts and, therefore, the price of the ticket does not qualify as a deductible charitable contribution.